nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupropion—CYP2C8—Mometasone—systemic scleroderma	0.151	0.287	CbGbCtD
Bupropion—CYP1A2—Pentoxifylline—systemic scleroderma	0.0792	0.15	CbGbCtD
Bupropion—CYP1A2—Leflunomide—systemic scleroderma	0.0755	0.143	CbGbCtD
Bupropion—CYP2C9—Leflunomide—systemic scleroderma	0.068	0.129	CbGbCtD
Bupropion—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.0603	0.114	CbGbCtD
Bupropion—CYP2D6—Captopril—systemic scleroderma	0.0488	0.0926	CbGbCtD
Bupropion—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0244	0.0464	CbGbCtD
Bupropion—CYP3A4—Prednisone—systemic scleroderma	0.0195	0.0371	CbGbCtD
Bupropion—CYP2C9—cardial valve—systemic scleroderma	0.00438	0.508	CbGeAlD
Bupropion—CHRNA3—skin of body—systemic scleroderma	0.000728	0.0845	CbGeAlD
Bupropion—CHRNA3—lung—systemic scleroderma	0.000487	0.0564	CbGeAlD
Bupropion—CYP2A6—lung—systemic scleroderma	0.000318	0.0368	CbGeAlD
Bupropion—ORM1—lung—systemic scleroderma	0.000289	0.0336	CbGeAlD
Bupropion—SLC6A3—lung—systemic scleroderma	0.000269	0.0312	CbGeAlD
Bupropion—CYP2B6—skin of body—systemic scleroderma	0.000239	0.0278	CbGeAlD
Bupropion—SLC6A2—lung—systemic scleroderma	0.000217	0.0252	CbGeAlD
Bupropion—CYP1A2—digestive system—systemic scleroderma	0.0002	0.0232	CbGeAlD
Bupropion—CYP2B6—digestive system—systemic scleroderma	0.000191	0.0222	CbGeAlD
Bupropion—CYP2C9—digestive system—systemic scleroderma	0.00019	0.022	CbGeAlD
Bupropion—CYP2E1—digestive system—systemic scleroderma	0.00018	0.0208	CbGeAlD
Bupropion—CYP2E1—tendon—systemic scleroderma	0.000171	0.0198	CbGeAlD
Bupropion—CYP1A2—lung—systemic scleroderma	0.000167	0.0193	CbGeAlD
Bupropion—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000347	CcSEcCtD
Bupropion—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000347	CcSEcCtD
Bupropion—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000347	CcSEcCtD
Bupropion—Myocardial infarction—Prednisone—systemic scleroderma	0.000161	0.000347	CcSEcCtD
Bupropion—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000161	0.000347	CcSEcCtD
Bupropion—Breast disorder—Methotrexate—systemic scleroderma	0.000161	0.000347	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000161	0.000346	CcSEcCtD
Bupropion—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000346	CcSEcCtD
Bupropion—Hypersensitivity—Azathioprine—systemic scleroderma	0.00016	0.000345	CcSEcCtD
Bupropion—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00016	0.000345	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000345	CcSEcCtD
Bupropion—CYP2B6—lung—systemic scleroderma	0.00016	0.0185	CbGeAlD
Bupropion—Insomnia—Lisinopril—systemic scleroderma	0.00016	0.000344	CcSEcCtD
Bupropion—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000343	CcSEcCtD
Bupropion—Paraesthesia—Lisinopril—systemic scleroderma	0.000158	0.000341	CcSEcCtD
Bupropion—Vomiting—Captopril—systemic scleroderma	0.000158	0.000341	CcSEcCtD
Bupropion—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000158	0.00034	CcSEcCtD
Bupropion—Dyspnoea—Lisinopril—systemic scleroderma	0.000157	0.000339	CcSEcCtD
Bupropion—Rash—Captopril—systemic scleroderma	0.000157	0.000338	CcSEcCtD
Bupropion—Dermatitis—Captopril—systemic scleroderma	0.000157	0.000338	CcSEcCtD
Bupropion—Somnolence—Lisinopril—systemic scleroderma	0.000157	0.000338	CcSEcCtD
Bupropion—Headache—Captopril—systemic scleroderma	0.000156	0.000336	CcSEcCtD
Bupropion—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000336	CcSEcCtD
Bupropion—Dyspepsia—Lisinopril—systemic scleroderma	0.000155	0.000335	CcSEcCtD
Bupropion—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000155	0.000334	CcSEcCtD
Bupropion—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000155	0.000334	CcSEcCtD
Bupropion—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000333	CcSEcCtD
Bupropion—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000333	CcSEcCtD
Bupropion—Asthma—Methotrexate—systemic scleroderma	0.000154	0.000332	CcSEcCtD
Bupropion—Infection—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000331	CcSEcCtD
Bupropion—Decreased appetite—Lisinopril—systemic scleroderma	0.000153	0.00033	CcSEcCtD
Bupropion—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000152	0.000328	CcSEcCtD
Bupropion—Fatigue—Lisinopril—systemic scleroderma	0.000152	0.000328	CcSEcCtD
Bupropion—Shock—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000328	CcSEcCtD
Bupropion—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000152	0.000327	CcSEcCtD
Bupropion—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000326	CcSEcCtD
Bupropion—Hypersensitivity—Leflunomide—systemic scleroderma	0.000151	0.000326	CcSEcCtD
Bupropion—Pancreatitis—Methotrexate—systemic scleroderma	0.000151	0.000325	CcSEcCtD
Bupropion—Pain—Lisinopril—systemic scleroderma	0.000151	0.000325	CcSEcCtD
Bupropion—Constipation—Lisinopril—systemic scleroderma	0.000151	0.000325	CcSEcCtD
Bupropion—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.000151	0.000325	CcSEcCtD
Bupropion—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00015	0.000323	CcSEcCtD
Bupropion—CYP2E1—lung—systemic scleroderma	0.00015	0.0174	CbGeAlD
Bupropion—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000322	CcSEcCtD
Bupropion—Diarrhoea—Azathioprine—systemic scleroderma	0.000149	0.00032	CcSEcCtD
Bupropion—Haemoglobin—Prednisone—systemic scleroderma	0.000148	0.000319	CcSEcCtD
Bupropion—Nausea—Captopril—systemic scleroderma	0.000148	0.000319	CcSEcCtD
Bupropion—Abdominal discomfort—Methotrexate—systemic scleroderma	0.000148	0.000318	CcSEcCtD
Bupropion—Haemorrhage—Prednisone—systemic scleroderma	0.000147	0.000318	CcSEcCtD
Bupropion—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000317	CcSEcCtD
Bupropion—Asthenia—Leflunomide—systemic scleroderma	0.000147	0.000317	CcSEcCtD
Bupropion—Hallucination—Prednisone—systemic scleroderma	0.000147	0.000316	CcSEcCtD
Bupropion—Pancytopenia—Methotrexate—systemic scleroderma	0.000146	0.000315	CcSEcCtD
Bupropion—Feeling abnormal—Lisinopril—systemic scleroderma	0.000145	0.000313	CcSEcCtD
Bupropion—Pruritus—Leflunomide—systemic scleroderma	0.000145	0.000313	CcSEcCtD
Bupropion—Connective tissue disorder—Prednisone—systemic scleroderma	0.000145	0.000312	CcSEcCtD
Bupropion—CYP3A4—digestive system—systemic scleroderma	0.000145	0.0168	CbGeAlD
Bupropion—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000311	CcSEcCtD
Bupropion—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000144	0.000311	CcSEcCtD
Bupropion—Dysuria—Methotrexate—systemic scleroderma	0.000144	0.00031	CcSEcCtD
Bupropion—Dizziness—Azathioprine—systemic scleroderma	0.000144	0.00031	CcSEcCtD
Bupropion—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000143	0.000308	CcSEcCtD
Bupropion—CYP2D6—digestive system—systemic scleroderma	0.000142	0.0165	CbGeAlD
Bupropion—Erectile dysfunction—Methotrexate—systemic scleroderma	0.000142	0.000306	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000303	CcSEcCtD
Bupropion—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000141	0.000303	CcSEcCtD
Bupropion—Asthenia—Mycophenolic acid—systemic scleroderma	0.000141	0.000303	CcSEcCtD
Bupropion—Diarrhoea—Leflunomide—systemic scleroderma	0.00014	0.000303	CcSEcCtD
Bupropion—Urticaria—Lisinopril—systemic scleroderma	0.00014	0.000302	CcSEcCtD
Bupropion—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000301	CcSEcCtD
Bupropion—Abdominal pain—Lisinopril—systemic scleroderma	0.000139	0.0003	CcSEcCtD
Bupropion—Body temperature increased—Lisinopril—systemic scleroderma	0.000139	0.0003	CcSEcCtD
Bupropion—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000139	0.000299	CcSEcCtD
Bupropion—Pruritus—Mycophenolic acid—systemic scleroderma	0.000139	0.000299	CcSEcCtD
Bupropion—Vomiting—Azathioprine—systemic scleroderma	0.000138	0.000298	CcSEcCtD
Bupropion—Pneumonia—Methotrexate—systemic scleroderma	0.000138	0.000297	CcSEcCtD
Bupropion—Eye disorder—Prednisone—systemic scleroderma	0.000138	0.000297	CcSEcCtD
Bupropion—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000138	0.000297	CcSEcCtD
Bupropion—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000137	0.000296	CcSEcCtD
Bupropion—Infestation NOS—Methotrexate—systemic scleroderma	0.000137	0.000296	CcSEcCtD
Bupropion—Infestation—Methotrexate—systemic scleroderma	0.000137	0.000296	CcSEcCtD
Bupropion—Rash—Azathioprine—systemic scleroderma	0.000137	0.000295	CcSEcCtD
Bupropion—Dermatitis—Azathioprine—systemic scleroderma	0.000137	0.000295	CcSEcCtD
Bupropion—Flushing—Prednisone—systemic scleroderma	0.000137	0.000295	CcSEcCtD
Bupropion—Headache—Azathioprine—systemic scleroderma	0.000136	0.000293	CcSEcCtD
Bupropion—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000136	0.000293	CcSEcCtD
Bupropion—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000136	0.000293	CcSEcCtD
Bupropion—Dizziness—Leflunomide—systemic scleroderma	0.000136	0.000292	CcSEcCtD
Bupropion—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000289	CcSEcCtD
Bupropion—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000134	0.000289	CcSEcCtD
Bupropion—Stomatitis—Methotrexate—systemic scleroderma	0.000134	0.000288	CcSEcCtD
Bupropion—Angiopathy—Prednisone—systemic scleroderma	0.000134	0.000288	CcSEcCtD
Bupropion—Conjunctivitis—Methotrexate—systemic scleroderma	0.000133	0.000287	CcSEcCtD
Bupropion—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000287	CcSEcCtD
Bupropion—Immune system disorder—Prednisone—systemic scleroderma	0.000133	0.000287	CcSEcCtD
Bupropion—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000285	CcSEcCtD
Bupropion—Pain—Mycophenolate mofetil—systemic scleroderma	0.000132	0.000285	CcSEcCtD
Bupropion—Arrhythmia—Prednisone—systemic scleroderma	0.000132	0.000284	CcSEcCtD
Bupropion—Sweating—Methotrexate—systemic scleroderma	0.000132	0.000284	CcSEcCtD
Bupropion—Vomiting—Leflunomide—systemic scleroderma	0.000131	0.000281	CcSEcCtD
Bupropion—Alopecia—Prednisone—systemic scleroderma	0.00013	0.000281	CcSEcCtD
Bupropion—Hypersensitivity—Lisinopril—systemic scleroderma	0.00013	0.00028	CcSEcCtD
Bupropion—Dizziness—Mycophenolic acid—systemic scleroderma	0.00013	0.000279	CcSEcCtD
Bupropion—Epistaxis—Methotrexate—systemic scleroderma	0.000129	0.000279	CcSEcCtD
Bupropion—Rash—Leflunomide—systemic scleroderma	0.000129	0.000279	CcSEcCtD
Bupropion—Dermatitis—Leflunomide—systemic scleroderma	0.000129	0.000279	CcSEcCtD
Bupropion—Mental disorder—Prednisone—systemic scleroderma	0.000129	0.000278	CcSEcCtD
Bupropion—Nausea—Azathioprine—systemic scleroderma	0.000129	0.000278	CcSEcCtD
Bupropion—Headache—Leflunomide—systemic scleroderma	0.000129	0.000277	CcSEcCtD
Bupropion—Malnutrition—Prednisone—systemic scleroderma	0.000128	0.000277	CcSEcCtD
Bupropion—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000127	0.000274	CcSEcCtD
Bupropion—Asthenia—Lisinopril—systemic scleroderma	0.000127	0.000273	CcSEcCtD
Bupropion—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000126	0.000272	CcSEcCtD
Bupropion—Pruritus—Lisinopril—systemic scleroderma	0.000125	0.000269	CcSEcCtD
Bupropion—Vomiting—Mycophenolic acid—systemic scleroderma	0.000125	0.000268	CcSEcCtD
Bupropion—Haemoglobin—Methotrexate—systemic scleroderma	0.000124	0.000267	CcSEcCtD
Bupropion—Rash—Mycophenolic acid—systemic scleroderma	0.000123	0.000266	CcSEcCtD
Bupropion—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000123	0.000266	CcSEcCtD
Bupropion—Hepatitis—Methotrexate—systemic scleroderma	0.000123	0.000266	CcSEcCtD
Bupropion—Haemorrhage—Methotrexate—systemic scleroderma	0.000123	0.000266	CcSEcCtD
Bupropion—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000265	CcSEcCtD
Bupropion—Headache—Mycophenolic acid—systemic scleroderma	0.000123	0.000264	CcSEcCtD
Bupropion—Pharyngitis—Methotrexate—systemic scleroderma	0.000122	0.000264	CcSEcCtD
Bupropion—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000263	CcSEcCtD
Bupropion—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000122	0.000263	CcSEcCtD
Bupropion—Nausea—Leflunomide—systemic scleroderma	0.000122	0.000263	CcSEcCtD
Bupropion—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000122	0.000262	CcSEcCtD
Bupropion—Vision blurred—Prednisone—systemic scleroderma	0.000121	0.000261	CcSEcCtD
Bupropion—Urethral disorder—Methotrexate—systemic scleroderma	0.000121	0.00026	CcSEcCtD
Bupropion—Diarrhoea—Lisinopril—systemic scleroderma	0.000121	0.00026	CcSEcCtD
Bupropion—Ill-defined disorder—Prednisone—systemic scleroderma	0.000119	0.000257	CcSEcCtD
Bupropion—Visual impairment—Methotrexate—systemic scleroderma	0.000119	0.000256	CcSEcCtD
Bupropion—Anaemia—Prednisone—systemic scleroderma	0.000119	0.000256	CcSEcCtD
Bupropion—Agitation—Prednisone—systemic scleroderma	0.000118	0.000254	CcSEcCtD
Bupropion—Angioedema—Prednisone—systemic scleroderma	0.000117	0.000253	CcSEcCtD
Bupropion—Dizziness—Lisinopril—systemic scleroderma	0.000117	0.000251	CcSEcCtD
Bupropion—Erythema multiforme—Methotrexate—systemic scleroderma	0.000117	0.000251	CcSEcCtD
Bupropion—Nausea—Mycophenolic acid—systemic scleroderma	0.000116	0.000251	CcSEcCtD
Bupropion—Malaise—Prednisone—systemic scleroderma	0.000116	0.000249	CcSEcCtD
Bupropion—Vertigo—Prednisone—systemic scleroderma	0.000115	0.000248	CcSEcCtD
Bupropion—Eye disorder—Methotrexate—systemic scleroderma	0.000115	0.000248	CcSEcCtD
Bupropion—Syncope—Prednisone—systemic scleroderma	0.000115	0.000248	CcSEcCtD
Bupropion—Tinnitus—Methotrexate—systemic scleroderma	0.000115	0.000248	CcSEcCtD
Bupropion—Cardiac disorder—Methotrexate—systemic scleroderma	0.000114	0.000246	CcSEcCtD
Bupropion—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000245	CcSEcCtD
Bupropion—Loss of consciousness—Prednisone—systemic scleroderma	0.000113	0.000243	CcSEcCtD
Bupropion—Vomiting—Lisinopril—systemic scleroderma	0.000112	0.000242	CcSEcCtD
Bupropion—Angiopathy—Methotrexate—systemic scleroderma	0.000112	0.000241	CcSEcCtD
Bupropion—Immune system disorder—Methotrexate—systemic scleroderma	0.000111	0.00024	CcSEcCtD
Bupropion—Rash—Lisinopril—systemic scleroderma	0.000111	0.00024	CcSEcCtD
Bupropion—Convulsion—Prednisone—systemic scleroderma	0.000111	0.00024	CcSEcCtD
Bupropion—Dermatitis—Lisinopril—systemic scleroderma	0.000111	0.000239	CcSEcCtD
Bupropion—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000111	0.000239	CcSEcCtD
Bupropion—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000111	0.000239	CcSEcCtD
Bupropion—Hypertension—Prednisone—systemic scleroderma	0.000111	0.000239	CcSEcCtD
Bupropion—Chills—Methotrexate—systemic scleroderma	0.000111	0.000238	CcSEcCtD
Bupropion—Headache—Lisinopril—systemic scleroderma	0.000111	0.000238	CcSEcCtD
Bupropion—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000109	0.000236	CcSEcCtD
Bupropion—Myalgia—Prednisone—systemic scleroderma	0.000109	0.000235	CcSEcCtD
Bupropion—Arthralgia—Prednisone—systemic scleroderma	0.000109	0.000235	CcSEcCtD
Bupropion—Anxiety—Prednisone—systemic scleroderma	0.000109	0.000235	CcSEcCtD
Bupropion—Alopecia—Methotrexate—systemic scleroderma	0.000109	0.000235	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000109	0.000234	CcSEcCtD
Bupropion—Discomfort—Prednisone—systemic scleroderma	0.000108	0.000233	CcSEcCtD
Bupropion—Mental disorder—Methotrexate—systemic scleroderma	0.000108	0.000233	CcSEcCtD
Bupropion—Malnutrition—Methotrexate—systemic scleroderma	0.000107	0.000231	CcSEcCtD
Bupropion—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000106	0.000228	CcSEcCtD
Bupropion—Dysgeusia—Methotrexate—systemic scleroderma	0.000105	0.000226	CcSEcCtD
Bupropion—Nausea—Lisinopril—systemic scleroderma	0.000105	0.000226	CcSEcCtD
Bupropion—Anaphylactic shock—Prednisone—systemic scleroderma	0.000105	0.000226	CcSEcCtD
Bupropion—Oedema—Prednisone—systemic scleroderma	0.000105	0.000226	CcSEcCtD
Bupropion—Infection—Prednisone—systemic scleroderma	0.000104	0.000224	CcSEcCtD
Bupropion—Back pain—Methotrexate—systemic scleroderma	0.000104	0.000224	CcSEcCtD
Bupropion—Shock—Prednisone—systemic scleroderma	0.000103	0.000222	CcSEcCtD
Bupropion—Nervous system disorder—Prednisone—systemic scleroderma	0.000103	0.000221	CcSEcCtD
Bupropion—Tachycardia—Prednisone—systemic scleroderma	0.000102	0.00022	CcSEcCtD
Bupropion—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000102	0.00022	CcSEcCtD
Bupropion—Skin disorder—Prednisone—systemic scleroderma	0.000102	0.000219	CcSEcCtD
Bupropion—Hyperhidrosis—Prednisone—systemic scleroderma	0.000101	0.000218	CcSEcCtD
Bupropion—Vision blurred—Methotrexate—systemic scleroderma	0.000101	0.000218	CcSEcCtD
Bupropion—Anorexia—Prednisone—systemic scleroderma	9.99e-05	0.000215	CcSEcCtD
Bupropion—Ill-defined disorder—Methotrexate—systemic scleroderma	9.95e-05	0.000214	CcSEcCtD
Bupropion—Anaemia—Methotrexate—systemic scleroderma	9.92e-05	0.000214	CcSEcCtD
Bupropion—Vomiting—Mycophenolate mofetil—systemic scleroderma	9.83e-05	0.000212	CcSEcCtD
Bupropion—Rash—Mycophenolate mofetil—systemic scleroderma	9.75e-05	0.00021	CcSEcCtD
Bupropion—Dermatitis—Mycophenolate mofetil—systemic scleroderma	9.74e-05	0.00021	CcSEcCtD
Bupropion—Headache—Mycophenolate mofetil—systemic scleroderma	9.68e-05	0.000209	CcSEcCtD
Bupropion—Malaise—Methotrexate—systemic scleroderma	9.67e-05	0.000208	CcSEcCtD
Bupropion—Vertigo—Methotrexate—systemic scleroderma	9.64e-05	0.000208	CcSEcCtD
Bupropion—Leukopenia—Methotrexate—systemic scleroderma	9.6e-05	0.000207	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Prednisone—systemic scleroderma	9.55e-05	0.000206	CcSEcCtD
Bupropion—Insomnia—Prednisone—systemic scleroderma	9.48e-05	0.000204	CcSEcCtD
Bupropion—Paraesthesia—Prednisone—systemic scleroderma	9.41e-05	0.000203	CcSEcCtD
Bupropion—Cough—Methotrexate—systemic scleroderma	9.36e-05	0.000202	CcSEcCtD
Bupropion—Convulsion—Methotrexate—systemic scleroderma	9.3e-05	0.0002	CcSEcCtD
Bupropion—Dyspepsia—Prednisone—systemic scleroderma	9.22e-05	0.000199	CcSEcCtD
Bupropion—Nausea—Mycophenolate mofetil—systemic scleroderma	9.18e-05	0.000198	CcSEcCtD
Bupropion—Chest pain—Methotrexate—systemic scleroderma	9.13e-05	0.000197	CcSEcCtD
Bupropion—Arthralgia—Methotrexate—systemic scleroderma	9.13e-05	0.000197	CcSEcCtD
Bupropion—Myalgia—Methotrexate—systemic scleroderma	9.13e-05	0.000197	CcSEcCtD
Bupropion—Decreased appetite—Prednisone—systemic scleroderma	9.11e-05	0.000196	CcSEcCtD
Bupropion—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.07e-05	0.000195	CcSEcCtD
Bupropion—Fatigue—Prednisone—systemic scleroderma	9.03e-05	0.000195	CcSEcCtD
Bupropion—Discomfort—Methotrexate—systemic scleroderma	9.02e-05	0.000194	CcSEcCtD
Bupropion—Constipation—Prednisone—systemic scleroderma	8.96e-05	0.000193	CcSEcCtD
Bupropion—Confusional state—Methotrexate—systemic scleroderma	8.83e-05	0.00019	CcSEcCtD
Bupropion—Anaphylactic shock—Methotrexate—systemic scleroderma	8.76e-05	0.000189	CcSEcCtD
Bupropion—Infection—Methotrexate—systemic scleroderma	8.7e-05	0.000187	CcSEcCtD
Bupropion—Feeling abnormal—Prednisone—systemic scleroderma	8.63e-05	0.000186	CcSEcCtD
Bupropion—Nervous system disorder—Methotrexate—systemic scleroderma	8.59e-05	0.000185	CcSEcCtD
Bupropion—Thrombocytopenia—Methotrexate—systemic scleroderma	8.57e-05	0.000185	CcSEcCtD
Bupropion—Gastrointestinal pain—Prednisone—systemic scleroderma	8.57e-05	0.000185	CcSEcCtD
Bupropion—Skin disorder—Methotrexate—systemic scleroderma	8.5e-05	0.000183	CcSEcCtD
Bupropion—Hyperhidrosis—Methotrexate—systemic scleroderma	8.46e-05	0.000182	CcSEcCtD
Bupropion—Anorexia—Methotrexate—systemic scleroderma	8.35e-05	0.00018	CcSEcCtD
Bupropion—Urticaria—Prednisone—systemic scleroderma	8.32e-05	0.000179	CcSEcCtD
Bupropion—Abdominal pain—Prednisone—systemic scleroderma	8.28e-05	0.000178	CcSEcCtD
Bupropion—Body temperature increased—Prednisone—systemic scleroderma	8.28e-05	0.000178	CcSEcCtD
Bupropion—Hypotension—Methotrexate—systemic scleroderma	8.18e-05	0.000176	CcSEcCtD
Bupropion—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	7.98e-05	0.000172	CcSEcCtD
Bupropion—Insomnia—Methotrexate—systemic scleroderma	7.92e-05	0.000171	CcSEcCtD
Bupropion—Paraesthesia—Methotrexate—systemic scleroderma	7.86e-05	0.000169	CcSEcCtD
Bupropion—Dyspnoea—Methotrexate—systemic scleroderma	7.81e-05	0.000168	CcSEcCtD
Bupropion—Somnolence—Methotrexate—systemic scleroderma	7.78e-05	0.000168	CcSEcCtD
Bupropion—Hypersensitivity—Prednisone—systemic scleroderma	7.72e-05	0.000166	CcSEcCtD
Bupropion—Dyspepsia—Methotrexate—systemic scleroderma	7.71e-05	0.000166	CcSEcCtD
Bupropion—Decreased appetite—Methotrexate—systemic scleroderma	7.61e-05	0.000164	CcSEcCtD
Bupropion—Gastrointestinal disorder—Methotrexate—systemic scleroderma	7.56e-05	0.000163	CcSEcCtD
Bupropion—Fatigue—Methotrexate—systemic scleroderma	7.55e-05	0.000163	CcSEcCtD
Bupropion—Asthenia—Prednisone—systemic scleroderma	7.52e-05	0.000162	CcSEcCtD
Bupropion—Pain—Methotrexate—systemic scleroderma	7.49e-05	0.000161	CcSEcCtD
Bupropion—Pruritus—Prednisone—systemic scleroderma	7.41e-05	0.00016	CcSEcCtD
Bupropion—Feeling abnormal—Methotrexate—systemic scleroderma	7.22e-05	0.000155	CcSEcCtD
Bupropion—Diarrhoea—Prednisone—systemic scleroderma	7.17e-05	0.000154	CcSEcCtD
Bupropion—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.16e-05	0.000154	CcSEcCtD
Bupropion—Urticaria—Methotrexate—systemic scleroderma	6.96e-05	0.00015	CcSEcCtD
Bupropion—Dizziness—Prednisone—systemic scleroderma	6.93e-05	0.000149	CcSEcCtD
Bupropion—Abdominal pain—Methotrexate—systemic scleroderma	6.92e-05	0.000149	CcSEcCtD
Bupropion—Body temperature increased—Methotrexate—systemic scleroderma	6.92e-05	0.000149	CcSEcCtD
Bupropion—Vomiting—Prednisone—systemic scleroderma	6.66e-05	0.000144	CcSEcCtD
Bupropion—Rash—Prednisone—systemic scleroderma	6.61e-05	0.000142	CcSEcCtD
Bupropion—Dermatitis—Prednisone—systemic scleroderma	6.6e-05	0.000142	CcSEcCtD
Bupropion—Headache—Prednisone—systemic scleroderma	6.56e-05	0.000141	CcSEcCtD
Bupropion—Hypersensitivity—Methotrexate—systemic scleroderma	6.45e-05	0.000139	CcSEcCtD
Bupropion—Asthenia—Methotrexate—systemic scleroderma	6.28e-05	0.000135	CcSEcCtD
Bupropion—Nausea—Prednisone—systemic scleroderma	6.22e-05	0.000134	CcSEcCtD
Bupropion—Pruritus—Methotrexate—systemic scleroderma	6.19e-05	0.000133	CcSEcCtD
Bupropion—Diarrhoea—Methotrexate—systemic scleroderma	5.99e-05	0.000129	CcSEcCtD
Bupropion—Dizziness—Methotrexate—systemic scleroderma	5.79e-05	0.000125	CcSEcCtD
Bupropion—Vomiting—Methotrexate—systemic scleroderma	5.57e-05	0.00012	CcSEcCtD
Bupropion—Rash—Methotrexate—systemic scleroderma	5.52e-05	0.000119	CcSEcCtD
Bupropion—Dermatitis—Methotrexate—systemic scleroderma	5.52e-05	0.000119	CcSEcCtD
Bupropion—Headache—Methotrexate—systemic scleroderma	5.49e-05	0.000118	CcSEcCtD
Bupropion—Nausea—Methotrexate—systemic scleroderma	5.2e-05	0.000112	CcSEcCtD
